• to reduce the potential risk of critical cardiovascular (coronary heart and blood vessel) difficulties in Grownups with style 2 diabetes and cardiovascular diseaseare scheduled to obtain surgical procedure or other procedures that use anesthesia or deep sleepiness (deep sedation)Only one company formally makes title-model semaglutide with FDA a